Skip to main content
Transactions of the Royal Society of Tropical Medicine and Hygiene logoLink to Transactions of the Royal Society of Tropical Medicine and Hygiene
. 2021 Mar 16;115(5):575. doi: 10.1093/trstmh/trab046

Corrigendum to: Medicine donation programmes supporting the global drive to end the burden of neglected tropical diseases

Mark Bradley 1,, Rachel Taylor 2, Julie Jacobson 3, Morgane Guex 4, Adrian Hopkins 5, Julie Jensen 6, Lynn Leonard 7, Johannes Waltz 8, Luc Kuykens 9, Papa Salif Sow 10, Ulrich-Dietmar Madeja 11, Takayuki Hidal 12, Kileken Ole-Moiyoi 13, Jonathan King 14, Daniel Argaw 15, Jamsheed Mohamed 16, Maria Rebollo Polo 17, Aya Yajima 18, Eric Ottesen 19
PMCID: PMC8106903  PMID: 33728461

Transactions of the Royal Society of Tropical Medicine and Hygiene, traa167, https://doi.org/10.1093/trstmh/traa167

In the originally published version of this article, errors relating to the incorrect use of the Merck corporate name were identified. This corrigendum addresses the changes that have subsequently been made in the ‘Medicine donation programmes for the neglected tropical diseases’ and ‘Lessons learned from the medicine donation Programmes’ sections. In both sections, mention of 'Merck & Co., Inc' should read: ‘Merck & Co., Inc., Rahway, NJ, USA’.

Contributor Information

Mark Bradley, Global Health, GSK, Brentford, UK.

Rachel Taylor, Corporate Responsibility, Merck & Co., Inc., Kenilworth, NJ, USA.

Julie Jacobson, Bridges to Development, Seattle, Washington, USA.

Morgane Guex, International Federation of Pharmaceutical Manufacturers and Associations, Geneva, Switzerland.

Adrian Hopkins, Adrian Hopkins Consulting, Gravesend, Kent, UK.

Julie Jensen, Global Health & Patient Access, Pfizer, Inc. New York, NY, USA.

Lynn Leonard, Johnson & Johnson Global Public Health, New Brunswick, NJ, USA.

Johannes Waltz, Global Health, Group Corporate Affairs Merck KGaA, Darmstadt, Germany.

Luc Kuykens, Global Health Programs, Sanofi, Paris, France.

Papa Salif Sow, Global Patient Solutions Africa, Gilead Sciences, Foster City, CA, USA.

Ulrich-Dietmar Madeja, Neglected Tropical Disease Programs, Bayer AG Pharmaceuticals, Berlin, Germany.

Takayuki Hidal, Sustainability, Eisai Co. Ltd, Tokyo, Japan.

Kileken Ole-Moiyoi, Novartis Global Health & Corporate Responsibility, Basel, Switzerland.

Jonathan King, Department of Control of Neglected Tropical Diseases, WHO Geneva, Geneva, Switzerland.

Daniel Argaw, Department of Control of Neglected Tropical Diseases, WHO Geneva, Geneva, Switzerland.

Jamsheed Mohamed, Department of Communicable Diseases WHO Regional Office for South-East Asia, Delhi, India.

Maria Rebollo Polo, Expanded Special Project for Elimination of NTDs (ESPEN) WHO Regional Office for Africa, Brazzaville, Congo.

Aya Yajima, Division of Programs for Disease Control WHO Regional Office for the Western Pacific, Manila, Philippines.

Eric Ottesen, NTD Support Centre, Task Force for Global Health Atlanta, USA.


Articles from Transactions of the Royal Society of Tropical Medicine and Hygiene are provided here courtesy of Oxford University Press

RESOURCES